[Chemical Constituents of the Aerial Parts from Plumbago zeylanica].

中药材 Pub Date : 2016-07-01

Xiao-guang Tang, Chao Wang, Xiao-chi Ma, Hou-li Zhang, Xiao-kui Huo, Bao-jing Zhang, Ming Zhong

{"title":"[Chemical Constituents of the Aerial Parts from Plumbago zeylanica].","authors":"Xiao-guang Tang, Chao Wang, Xiao-chi Ma, Hou-li Zhang, Xiao-kui Huo, Bao-jing Zhang, Ming Zhong","doi":"","DOIUrl":null,"url":null,"abstract":"Objective: To study the anti-oxidative constituents of the aerial parts of Plumbago zeylanica.Methods: The ethanol extract of Plumbago zeylanica was separated and purified by various chromatographic techniques. On the basis of various spectroscopic data, the structures of isolated compounds were elucidated. ABTS+radical scavenging were carried out in antioxidant activity evaluation of the isolated compounds.Results: Eleven compounds were isolated and identified as cis-isoshinanolone-4-O-β-D-glucopyranoside( 1),tachioside( 2),2,6-dimethoxy-p-hydroquinone-1-O-β-D-glucopyranoside( 3),3-( β-D-glucopyranosyloxy)-4-methoxybenzoic acid( 4),3’-O-β-D-glucopyranosyloxy-plumbagic acid( 5),3’-O-β-D-glucopyranosyloxy-plumbagic acid methyl ester( 6),plumbagic acid( 7),plumbagine A( 8),plumbagine C( 9),syringate-4-O-β-D-glucopyranoside( 10) and 2-methyl-5-hydroxychromone( 11). Compounds 2,3,and5 displayed significant scavenging effect on ABTS+.Conclusion: Compounds 1 ~ 4,10,11 are obtained from this plant for the first time. Compounds 2,3,and 5 show significant anti-oxidative effects.","PeriodicalId":15312,"journal":{"name":"中药材","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中药材","FirstCategoryId":"3","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To study the anti-oxidative constituents of the aerial parts of Plumbago zeylanica.

Methods: The ethanol extract of Plumbago zeylanica was separated and purified by various chromatographic techniques. On the basis of various spectroscopic data, the structures of isolated compounds were elucidated. ABTS+radical scavenging were carried out in antioxidant activity evaluation of the isolated compounds.

Results: Eleven compounds were isolated and identified as cis-isoshinanolone-4-O-β-D-glucopyranoside( 1),tachioside( 2),2,6-dimethoxy-p-hydroquinone-1-O-β-D-glucopyranoside( 3),3-( β-D-glucopyranosyloxy)-4-methoxybenzoic acid( 4),3’-O-β-D-glucopyranosyloxy-plumbagic acid( 5),3’-O-β-D-glucopyranosyloxy-plumbagic acid methyl ester( 6),plumbagic acid( 7),plumbagine A( 8),plumbagine C( 9),syringate-4-O-β-D-glucopyranoside( 10) and 2-methyl-5-hydroxychromone( 11). Compounds 2,3,and5 displayed significant scavenging effect on ABTS+.

Conclusion: Compounds 1 ~ 4,10,11 are obtained from this plant for the first time. Compounds 2,3,and 5 show significant anti-oxidative effects.

本刊更多论文

[白花柏树气部的化学成分]。

目的:研究泽兰花地上部位的抗氧化成分。方法:采用多种色谱技术对白花苜蓿乙醇提取物进行分离纯化。根据各种光谱数据，对分离化合物的结构进行了分析。对分离得到的化合物进行ABTS+自由基清除的抗氧化活性评价。结果:共分离得到11个化合物，分别为顺式异辛诺酮-4- o -β- d -葡萄糖苷(1)、桃核苷(2)、2,6-二甲氧基对对苯二酚-1- o -β- d -葡萄糖苷(3)、3-(β- d -葡萄糖苷)-4-甲氧基苯甲酸(4)、3 ' - o -β- d -葡萄糖苷-葡萄糖苷甲酯(5)、3 ' - o -β- d -葡萄糖苷-葡萄糖苷甲酯(6)、铅柏酸(7)、铅柏碱A(8)、铅柏碱C(9)、丁香-4- o -β- d -葡萄糖苷甲酯(10)和2-甲基-5-羟色酮(11)。化合物2、3、5对ABTS+具有明显的清除作用。结论:化合物1 ~ 4、10、11为首次从该植物中分离得到。化合物2、3和5具有显著的抗氧化作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中药材

自引率

0.00%

发文量

11364

期刊介绍： "Chinese Materia Medica" magazine was founded in 1978. It is a national-level academic journal of Chinese medicine science and technology approved by the State Science and Technology Commission and the Press and Publication Administration for public distribution at home and abroad. It is sponsored by the Chinese Materia Medica Information Center of the State Food and Drug Administration and is publicly distributed at home and abroad. It mainly reports on new technologies, new methods and new achievements in the production, scientific research and business management of Chinese medicine, and serves to promote the production and scientific and technological development of Chinese medicine, improve the output and quality of Chinese medicine, improve business management, and prosper the Chinese medicine industry.